Andrew M. Siedlecki

2.4k total citations · 2 hit papers
36 papers, 1.6k citations indexed

About

Andrew M. Siedlecki is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Andrew M. Siedlecki has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Andrew M. Siedlecki's work include Acute Kidney Injury Research (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Complement system in diseases (6 papers). Andrew M. Siedlecki is often cited by papers focused on Acute Kidney Injury Research (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Complement system in diseases (6 papers). Andrew M. Siedlecki collaborates with scholars based in United States, Canada and Italy. Andrew M. Siedlecki's co-authors include William Irish, Daniel C. Brennan, Anthony J. Muslin, Xiaohua Jin, Joseph V. Bonventre, Kelly M. McNagny, Hongxia Fu, Vishesh Agrawal, Ryuji Morizane and Jing Zhou and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew M. Siedlecki

33 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Delayed Graft Function in the Kidney Transplant

2011 572 citations Andrew M. Siedlecki et al. American Journal of Transplantation profile →
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

2015 567 citations Benjamin Freedman, Craig R. Brooks et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew M. Siedlecki United States	14	614	536	480	344	317	36	1.6k
Omar H. Maarouf United States	17	617 1.0×	377 0.7×	104 0.2×	150 0.4×	113 0.4×	24	1.2k
Anja Reutzel‐Selke Germany	23	348 0.6×	1.1k 2.1×	455 0.9×	98 0.3×	297 0.9×	87	1.8k
Ari Mennander Finland	28	588 1.0×	984 1.8×	404 0.8×	778 2.3×	60 0.2×	122	2.6k
Ryoichi Imamura Japan	22	287 0.5×	352 0.7×	237 0.5×	272 0.8×	84 0.3×	134	1.4k
Marilena Mister Italy	21	246 0.4×	294 0.5×	293 0.6×	127 0.4×	72 0.2×	34	1.1k
Ryoichi Shiroki Japan	16	170 0.3×	427 0.8×	109 0.2×	336 1.0×	118 0.4×	128	1.0k
Lars Wennberg Sweden	24	273 0.4×	890 1.7×	507 1.1×	100 0.3×	197 0.6×	97	1.8k
Hongfeng Huang China	15	243 0.4×	264 0.5×	237 0.5×	123 0.4×	83 0.3×	66	927
Christian Svalander Sweden	20	170 0.3×	335 0.6×	230 0.5×	121 0.4×	81 0.3×	37	957
Peter P. Frohnert United States	16	250 0.4×	309 0.6×	190 0.4×	423 1.2×	184 0.6×	32	1.1k

Countries citing papers authored by Andrew M. Siedlecki

Since Specialization

Citations

This map shows the geographic impact of Andrew M. Siedlecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Siedlecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Siedlecki more than expected).

Fields of papers citing papers by Andrew M. Siedlecki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Siedlecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Siedlecki. The network helps show where Andrew M. Siedlecki may publish in the future.

Co-authorship network of co-authors of Andrew M. Siedlecki

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Siedlecki. A scholar is included among the top collaborators of Andrew M. Siedlecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Siedlecki. Andrew M. Siedlecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yi, Janewit Wongboonsin, Stefanie W. Benoit, et al.. (2022). A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury. Kidney International Reports. 7(12). 2714–2717. 4 indexed citations

Al‐Dakkak, Imad, Gianluigi Ardissino, Laurence Greenbaum, et al.. (2022). FC 115: Long-Term Outcomes in Eculizumab-Treated Kidney Transplant Patients Enrolled in the Global Atypical Haemolytic Uraemic Syndrome Registry. Nephrology Dialysis Transplantation. 37(Supplement_3). 1 indexed citations

Aghayev, Ayaz, et al.. (2021). Transplant renal artery and vein occlusion evaluated with ferumoxytol-enhanced magnetic resonance angiography. Clinical Imaging. 77. 142–146. 2 indexed citations

Li, Yi, et al.. (2021). Potential Role of 3-Dimensional Printed Vascular Models in Maintenance Hemodialysis Care. Kidney Medicine. 3(6). 1095–1098. 2 indexed citations

Ariceta, Gema, Fádi Fakhouri, Lisa Sartz, et al.. (2021). Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes. Clinical Kidney Journal. 14(9). 2075–2084. 12 indexed citations

Miller, Timothy L., et al.. (2020). Ferumoxytol-Enhanced Coronary Magnetic Resonance Angiography Compared to Invasive Coronary Angiography for Detection of Epicardial Coronary Artery Disease. Kidney Medicine. 3(1). 139–141. 5 indexed citations

Aghayev, Ayaz, et al.. (2020). Pseudoaneurysm-induced renal artery stenosis. Kidney International. 97(3). 617–617. 1 indexed citations

Wang, Xiaojie, Jialing Liu, Wenqing Yin, et al.. (2020). miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature. American Journal Of Pathology. 190(3). 642–659. 16 indexed citations

Zhang, Hongmei, Litao Ruan, Furong Zhang, et al.. (2019). Von Mises Strain as a Risk Marker for Vulnerability of Carotid Plaque: Preliminary Clinical Evaluation of Cerebral Infarction. Ultrasound in Medicine & Biology. 45(5). 1221–1233. 7 indexed citations

10.

Kazé, Arnaud D., Andrew M. Siedlecki, Stefan G. Tullius, et al.. (2018). Association of Cold Ischemia Time With Acute Renal Transplant Rejection. Transplantation. 102(7). 1188–1194. 33 indexed citations

11.

Steigner, Michael L., et al.. (2017). Intraluminal Assessment of Coronary Arteries With Ferumoxytol-Enhanced Magnetic Resonance Angiography. JACC. Cardiovascular imaging. 11(3). 505–508. 5 indexed citations

12.

Reddy, Yuvaram N.V., Andrew M. Siedlecki, & Jean Francis. (2016). Breaking down the complement system. Current Opinion in Nephrology & Hypertension. 26(2). 1–1. 25 indexed citations

13.

Mukundan, Srinivasan, Michael L. Steigner, Li‐Li Hsiao, et al.. (2016). Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD. American Journal of Kidney Diseases. 67(6). 984–988. 20 indexed citations

14.

Freedman, Benjamin, Craig R. Brooks, Albert Q. Lam, et al.. (2015). Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nature Communications. 6(1). 8715–8715. 567 indexed citations breakdown →

15.

Tsui, Edmund, et al.. (2015). Implementation of a vision-screening program in rural northeastern United States. Clinical ophthalmology. 1883–1883. 5 indexed citations

16.

Parikh, Bijal A., Andrew M. Siedlecki, & Mitchell G. Scott. (2010). Specificity of a Circulating Antibody That Interferes With a Widely Used Tacrolimus Immunoassay. Therapeutic Drug Monitoring. 32(2). 228–231. 14 indexed citations

17.

Siedlecki, Andrew M., J. Anderson, Xiaohua Jin, et al.. (2009). RGS4 Controls Renal Blood Flow and Inhibits Cyclosporine-Mediated Nephrotoxicity. American Journal of Transplantation. 10(2). 231–241. 19 indexed citations

18.

Siedlecki, Andrew M., Xiaohua Jin, & Anthony J. Muslin. (2009). Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney International. 75(8). 800–808. 81 indexed citations

19.

Siedlecki, Andrew M., John J. Curtis, Robert S. Gaston, et al.. (2007). The Impact of Left Ventricular Systolic Dysfunction on Survival After Renal Transplantation. Transplantation. 84(12). 1610–1617. 39 indexed citations

20.

Siedlecki, Andrew M., Jill Barker, & Michael Allon. (2007). Aneurysm Formation in Arteriovenous Grafts: Associations and Clinical Significance. Seminars in Dialysis. 20(1). 73–77. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact